Stay updated on Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.

Latest updates to the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page
- CheckyesterdayChange DetectedRevision label on the page was updated from v3.6.3 to v3.6.4, indicating a minor version update of the page. No substantive study content or functionality changes are implied by this update.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page footer now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates a refreshed page version without changing trial content.SummaryDifference0.0%

- Check30 days agoChange DetectedA new page revision tag, v3.6.2, was added, replacing the previous v3.6.0, indicating a minor update to the page revision metadata without altering the study details.SummaryDifference0.0%

- Check44 days agoChange DetectedRecruitment status is updated to no longer enrolling participants, affecting eligibility and opportunities to join. The page also adds new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and applies a minor heading reformating for Intervention/Treatment, along with a revision update to v3.6.0.SummaryDifference0.4%

- Check51 days agoChange DetectedA new revision version, v3.5.5, has been added to the page, replacing the previous v3.5.4. This indicates a minor update to the page's versioning and record-keeping.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page's revision label shows v3.5.4, replacing the previous v3.5.3. This indicates a minor internal update to the page without changes to the main content.SummaryDifference0.0%

Stay in the know with updates to Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.